Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

نویسندگان

  • Michele Ceccarelli
  • Floris P. Barthel
  • Tathiane M. Malta
  • Thais S. Sabedot
  • Sofie R. Salama
  • Bradley A. Murray
  • Olena Morozova
  • Yulia Newton
  • Amie Radenbaugh
  • Stefano M. Pagnotta
  • Samreen Anjum
  • Jiguang Wang
  • Ganiraju Manyam
  • Pietro Zoppoli
  • Shiyun Ling
  • Arjun A. Rao
  • Mia Grifford
  • Andrew D. Cherniack
  • Hailei Zhang
  • Laila Poisson
  • Carlos Gilberto Carlotti
  • Daniela Pretti da Cunha Tirapelli
  • Arvind Rao
  • Tom Mikkelsen
  • Ching C. Lau
  • W. K. Alfred Yung
  • Raul Rabadan
  • Jason Huse
  • Daniel J. Brat
  • Norman L. Lehman
  • Jill S. Barnholtz-Sloan
  • Siyuan Zheng
  • Kenneth Hess
  • Ganesh Rao
  • Matthew Meyerson
  • Rameen Beroukhim
  • Lee Cooper
  • Rehan Akbani
  • Margaret Wrensch
  • David Haussler
  • Kenneth D. Aldape
  • Peter W. Laird
  • David H. Gutmann
  • Houtan Noushmehr
  • Antonio Iavarone
  • Roel G.W. Verhaak
چکیده

Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic glioma driving alterations and suboptimal disease classification. We defined the complete set of genes associated with 1,122 diffuse grade II-III-IV gliomas from The Cancer Genome Atlas and used molecular profiles to improve disease classification, identify molecular correlations, and provide insights into the progression from low- to high-grade disease. Whole-genome sequencing data analysis determined that ATRX but not TERT promoter mutations are associated with increased telomere length. Recent advances in glioma classification based on IDH mutation and 1p/19q co-deletion status were recapitulated through analysis of DNA methylation profiles, which identified clinically relevant molecular subsets. A subtype of IDH mutant glioma was associated with DNA demethylation and poor outcome; a group of IDH-wild-type diffuse glioma showed molecular similarity to pilocytic astrocytoma and relatively favorable survival. Understanding of cohesive disease groups may aid improved clinical outcomes.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Circulatory YKL-40 & NLR: Underestimated Prognostic Indicators in Diffuse Glioma

In addition to histopathological parameters, evaluation of associated hematological factors is essential for devising a sensitive prognostic scale in glioma. Increased neutrophil-lymphocyte ratio (NLR), a marker of systemic inflammatory response, has recently been associated with worse outcome in various cancers. Given that glioma progression is characterized by inflammation, aggressive angioge...

متن کامل

Types of glioma brain tumors and genetic alterations in signaling pathways in them

Types of glioma brain tumors and genetic alterations in signaling pathways in them Background & Objective: Glioma is a common type of primary brain tumor originating in the glial cells that surrounds and supports neurons in the brain. These tumors arise from three different types of cells that are normally found in the brain: astrocytes, oligodendrocytes, and ependymal cells, accordingly types ...

متن کامل

EMT related lncrnas’ as novel biomarkers in glioblastoma: a review article

Glioma is the most common type of brain tumor and according to the 2016 WHO classification, based on invasion level, it is divided into four categories. The most severe and invasive type is grade IV glioma or glioblastoma (GBM), which has a very poor prognosis and a survival rate of only 15 months. However, the molecular pathway of invasion in malignant glioma tumors has not yet been clearly el...

متن کامل

Human Cancer Biology IDHMutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma

Purpose:Diffuse gliomas represent the most prevalent class of primary brain tumor. Despite significant recent advances in the understanding of glioblastoma [World Health Organization (WHO) IV], its most malignant subtype, lower grade (WHO II and III) glioma variants remain comparatively understudied, especially in light of their notable clinical heterogeneity. Accordingly, we sought to identify...

متن کامل

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

PURPOSE Diffuse gliomas represent the most prevalent class of primary brain tumor. Despite significant recent advances in the understanding of glioblastoma [World Health Organization (WHO) IV], its most malignant subtype, lower grade (WHO II and III) glioma variants remain comparatively understudied, especially in light of their notable clinical heterogeneity. Accordingly, we sought to identify...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cell

دوره 164  شماره 

صفحات  -

تاریخ انتشار 2016